 sinemet open-label studi sever parkinson diseas almost patient idiopath parkinson diseas respond overal dosag time sinemet attract method gradual sustain releas levodopa time physiolog striatal dopamin receptor earli stage diseas studi patient moder parkinson diseas sinemet period eleven patient full year therapi subject withdraw subject non-parkinson disease-rel ill therapeut benefit minim period therapeut benefit sever dystonia overal levodopa dosag patient side-effect levodopa patient nocturn benefit long-act prepar patient studi slow onset action sinemet early-morn immobl sinemet standard sinemet use form adjunct therapi patient